Evidence map›Paper›PMID 36382651›Full record

ArticlePsychotherapy and psychosomatics2022

Operational Definitions of Treatment Response and Remission in Obsessive-Compulsive Disorder Capture Meaningful Improvements in Everyday Life.

David Mataix-Cols, Erik Andersson, Kristina Aspvall, Julia Boberg, James J Crowley, Elles de Schipper, Lorena Fernández de la Cruz, Oskar Flygare, Ekaterina Ivanova, Fabian Lenhard and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Psychotherapy and psychosomatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Altered Striatal Functional Gradients in Obsessive-Compulsive Disorder.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2025
    Article
  6. Altered striatal functional gradients in obsessive-compulsive disorder.medRxiv : the preprint server for health sciences · 2025
    Article
  7. Association Between Polygenic Risk and Symptom Severity Change After Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2025
    Article
  8. Minimal clinically important difference in obsessive-compulsive disorder.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
    Article
  9. Article
  10. The minimal important difference in obsessive-compulsive disorder: An analysis of double-blind SSRI trials in adults.European psychiatry : the journal of the Association of European Psychiatrists · 2024
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

David Mataix-ColsDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Erik AnderssonDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Kristina AspvallDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Julia BobergDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
James J CrowleyDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Elles de SchipperDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Lorena Fernández de la CruzDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Oskar FlygareDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Ekaterina IvanovaDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Fabian LenhardDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Lina LundströmDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Christian RückDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Eva SerlachiusDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Matti CervinDepartment of Clinical Sciences Lund, Lund University, Lund, Sweden.
Karolinska Institutet · SELund University · SEUniversity of North Carolina at Chapel Hill · US

Funding

OCD: Novel Comparative Genomic Approaches to Identify Disease and Treatment MechanismsR01MH110427 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CROWLEY, JAMES JOSEPH · 2016 to 2021
$3.0M
NIMH NIH HHS R01 MH110427
6 · The paper itself

Abstract

introductionThe operational definitions of treatment response, partial response, and remission in obsessive-compulsive disorder (OCD) are widely used in clinical trials and regular practice. However, the clinimetric sensitivity of these definitions, that is, whether they identify patients that experience meaningful changes in their everyday life, remains unexplored.

objectiveThe objective was to examine the clinimetric sensitivity of the operational definitions of treatment response, partial response, and remission in children and adults with OCD.

methodsPre- and post-treatment data from five clinical trials and three cohort studies of children and adults with OCD (n = 1,528; 55.3% children, 61.1% female) were pooled. We compared (1) responders, partial responders, and non-responders and (2) remitters and non-remitters on self-reported OCD symptoms, clinician-rated general functioning, and self-reported quality of life. Remission was also evaluated against post-treatment diagnostic interviews.

resultsResponders and remitters experienced large improvements across validators. Responders had greater improvements than partial responders and non-responders on self-reported OCD symptoms (Cohen's d 0.65-1.13), clinician-rated functioning (Cohen's d 0.53-1.03), and self-reported quality of life (Cohen's d 0.63-0.73). Few meaningful differences emerged between partial responders and non-responders. Remitters had better outcomes across most validators than non-remitters. Remission criteria corresponded well with absence of post-treatment diagnosis (sensitivity/specificity: 93%/83%). Using both the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and the Clinical Global Impression Scale yielded more conservative results and more robust changes across validators, compared to only using the Y-BOCS.

conclusionsThe current definitions of treatment response and remission capture meaningful improvements in the everyday life of individuals with OCD, whereas the concept of partial response has dubious clinimetric sensitivity.

Indexed as

Obsessive-Compulsive DisorderQuality of LifeAdultChildFemaleHumansMaleResearch DesignSelf ReportSensitivity and SpecificityTreatment OutcomeObsessive-compulsive disorderPartial responseRecoveryRemissionResponse

Identifiers

PMID36382651
PMCPMC9838085
OpenAlexW4307711553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.